Estrogen receptors in the female heart and in a rat model of heart failure with preserved ejection fraction

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Petra Buettner

Heart Center of Leipzig, Leipzig (Germany)

4 More presentations in this session

Presentation thumbnail

Prognostic significance of functional mitral regurgitation in patients with HFpEF and atrial fibrillation after optimal medical therapies

Doctor S. Adam (Ndjamena, TD)

Abstract Slides Video

Presentation thumbnail

Epigenetic editing of BET proteins restores autophagy and cardiac function in cardiometabolic heart failure with preserved ejection fraction

Doctor L. Di Venanzio (Zurich, CH)

Abstract Slides Video

Presentation thumbnail

Iron metabolism in patients with left ventricular ejection fraction above 45%

Doctor J. Dodulik (Ostrava, CZ)

Abstract Slides Video

Presentation thumbnail

Coronary microcirculation in patients with diabetes Mellitus and heart failure with preserved ejection fraction.

Doctor E. Tatsis (Athens, GR)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in chronic heart failure - heart failure with HFpEF

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

Establishment of a female HFpEF model using Dahl salt-sensitive rats and investigation of sympathetic activation-induced acute exacerbation of HFpEF

Congress Presentation

Effects of sacubitril-valsartan alone or in combination with dapagliflozin on aging-related heart failure with preserved ejection fraction

Congress Presentation

A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources